Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial.
<h4>Background</h4>The efficacy and cost-effectiveness of prophylactic thrombolytic locks in hemodialysis patients at high-risk of thrombotic dialysis catheter dysfunction is uncertain. We investigated this question in a double-blinded randomized controlled study.<h4>Methods</h4...
Guardado en:
Autores principales: | Florence Bonkain, Jean-Claude Stolear, Concetta Catalano, Dominique Vandervelde, Serge Treille, Marie M Couttenye, Annemieke Dhondt, Mark Libertalis, Mandelina Allamani, Philippe Madhoun, Amaryllis H Van Craenenbroeck, Floris Vanommeslaeghe, Freya Van Hulle, Philippe Durieux, Ingrid Van Limberghen, Christian Tielemans, Karl Martin Wissing |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/874c58bd249d4dae8b2a65bec877f305 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.
por: Francesco Caruso, et al.
Publicado: (2010) -
Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
por: Yong Liu, et al.
Publicado: (2013) -
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Maria Vincenza Carriero, et al.
Publicado: (2017) -
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
por: Tobias Kromann-Hansen, et al.
Publicado: (2017) -
Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
por: Eva Haastrup, et al.
Publicado: (2014)